Download presentation
Presentation is loading. Please wait.
Published byElly Brinkerhoff Modified over 5 years ago
1
Introduction to Clinical Pharmacology Chapter 16 Opioid Antagonists
2
Opioid (Narcotic) Antagonists #1
Naltrexone is used to help treat alcohol dependency Actions for Naxolone Antagonist: competes for opiate receptor sites Reverses all effects; pain will return Restores respiratory function No opioid: antagonist has no drug activity Will work within 1 to 2 minutes
3
Opioid (Narcotic) Antagonists #2
Uses Postoperative acute respiratory depression, reversal of opioid adverse effects, which includes constipation, analgesia, hypotension, and bradycardia, reversal of and suspected acute opioid overdosage Adverse reactions Nausea, vomiting, sweating, tachycardia, increased blood pressure, tremors
4
Opioid (Narcotic) Antagonists #3
Contraindications, precautions, interactions Hypersensitivity, pregnancy category B, infants of opioid-dependent mothers, patients with opioid dependency, cardiovascular disease, and lactation Need to be aware of possible uses for opioids such as for coughs, for analgesia, and for diarrhea and ensure that antagonists should be given Withdrawal symptoms: opioid dependent
5
Nursing Process: Assessment #1
Preadministration assessment: Long-term opioid therapy: tolerant to physical adverse effects Risk for respiratory depression Somnolence and pain relief: slows breathing pattern Coach breathing pattern
6
Nursing Process: Assessment #2
Obtain blood pressure, pulse, and respiratory rate Review record for drug suspected of causing respiratory depression symptoms Review initial health history, allergy history, treatment modalities
7
Nursing Process: Assessment #3
Ongoing assessment Monitor blood pressure, pulse, and respiratory rate at frequent intervals and vital signs every 5 to 15 minutes after patient responsive Adverse drug reactions: notify primary health care provider Continue to monitor vital signs until effects of opioid wear off
8
Nursing Process: Assessment #4
Nursing Alert Repeated dose needed if results from initial dose unsatisfactory Duration of close patient observation depends on response to opioid antagonist
9
Nursing Process: Planning and Implementation #1
Return to normal respiratory rate, rhythm, and depth; adequate ventilation of body; continued pain relief Implementation: promoting an optimal response to therapy Naloxone: used in postanesthesia recovery unit Balance pain relief
10
Nursing Process: Planning and Implementation #2
Monitoring and managing patient needs Impaired spontaneous ventilation Naloxone: cardiac monitoring, artificial ventilation, suction equipment to suction as needed, maintain patent airway, if allowed be able to turn the client on side as needed to prevent possible aspiration Naloxone by IV infusion: secondary line, IV piggyback, IV push
11
Nursing Process: Planning and Implementation #3
Nursing Alert Slow IV push: somnolence abates- if pushed too fast can have withdrawal or intense pain Acute pain Assess pain and begin to treat pain again, review circumstances that led to use of antagonist, educate family, monitor fluid intake and output
12
Nursing Process: Evaluation
The therapeutic effect is achieved The patient’s respiratory rate, rhythm, and depth are normal Pain relief is resumed
13
Question #1 Is the following statement true or false?
An opioid antagonist increases the effects of an opioid drug.
14
Answer to Question #1 False
An opioid antagonist reverses the effects of an opioid drug. This is used when patients experience extreme adverse reactions such as respiratory depression.
15
Question #2 Is the following statement true or false?
Patients who seldom use opioid pain relievers are termed opioid naive, and they are at the greatest risk of experiencing respiratory depression when administered opioids.
16
Answer to Question #2 True
Patients who seldom use opioid pain relievers are termed opioid naive, and they are at the greatest risk of experiencing respiratory depression when administered opioids.
Similar presentations
© 2024 SlidePlayer.com. Inc.
All rights reserved.